Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2010(23): 4068-4074
DOI: 10.1055/s-0030-1258275
DOI: 10.1055/s-0030-1258275
PAPER
© Georg Thieme Verlag
Stuttgart ˙ New York
Synthesis of 2-Amino-5-hydroxycaprolactam Derivatives Mediated by E-Selective Olefination and Asymmetric Oxidation of the Enol Ether
Further Information
Received
5 August 2010
Publication Date:
30 September 2010 (online)
Publication History
Publication Date:
30 September 2010 (online)
Abstract
The asymmetric synthesis of 2-amino-5-hydroxycaprolactam derivatives is essential for exploring the antitumor properties of ester-bearing bengamides. In this study, chiral caprolactam isomers were achieved on the basis of highly E-selective Wittig olefination, asymmetric oxidations of the E-enol ethers, reductive amination of the aldehyde derivatives, cyclization of the 5-hydroxylysine analogues or/and deprotection.
Key words
caprolactam - E-selective olefination - asymmetric oxidation - enol ether - reductive amination
- Supporting Information for this article is available online:
- Supporting Information
-
1a
Quinoa E.Adamczeski M.Crews P.Bakus GJ.
J. Org. Chem. 1986, 51: 4494 -
1b
Adamczeski M.Quinoa E.Crews P. J. Am. Chem. Soc. 1989, 111: 647 - 2
Towbin H.Bair KW.DeCaprio JA.Eck MJ.Kim S.Kinder FR.Morollo A.Mueller DR.Schindler P.Song HK.van Oostrum J.Versace RW.Voshol H.Wood J.Zabludoff S.Phillips PE. J. Biol. Chem. 2003, 278: 52964 -
3a
Thale Z.Kinder FR.Bair KW.Bontempo J.Czuchta AM.Versace RW.Phillips PE.Sanders ML.Wattanasin S.Crews P. J. Org. Chem. 2001, 66: 1733 -
3b
Kinder FR.Versace RW.Bair KW.Bontempo JM.Cesarz D.Chen S.Crews P.Czuchta AM.Jagoe CT.Mou Y.Nemzek R.Phillips PE.Tran LD.Wang RM.Weltchek S.Zabludoff S. J. Med. Chem. 2001, 44: 3692 - 4
Kim S.LaMontagne K.Sabio M.Sharma S.Versace RW.Yusuff N.Phillips PE. Cancer Res. 2004, 64: 2984 - 5
Kinder FR.Wattanasin S.Versace RW.Bair KW.Bontempo J.Green MA.Lu YJ.Marepalli HR.Phillips PE.Roche D.Tran LD.Wang RM.Waykole L.Xu DD.Zabludoff S. J. Org. Chem. 2001, 66: 118 ; and references therein -
6a
Löhr B.Orlich S.Kunz H. Synlett 1999, 139 -
6b
Adamczyk M.Reddy RE.Rege SD. J. Labelled Compd. Radiopharm. 2001, 44: 185 -
6c
van den Nieuwendijk AMCH.Kriek NMAJ.Brussee J.van Boom JH.van der Gen A. Eur. J. Org. Chem. 2000, 3683 -
7a
Broka CA.Ehrler J. Tetrahedron Lett. 1991, 32: 5907 -
7b
Roche D.Prasad K.Repic O.Blacklock TJ. Tetrahedron Lett. 2001, 42: 1459 ; and references therein -
7c
Boeckman RK.Clark TJ.Shook BC. Org. Lett. 2002, 4: 2109 -
7d
Liu G.Tai W.-Y.Li Y.-L.Nan F.-J. Tetrahedron Lett. 2006, 47: 3295 - 8
Jacobsen EN.Zhang W.Muci AR.Ecker JR.Deng L. J. Am. Chem. Soc. 1991, 113: 7063 - 9
Sharpless KB.Amberg W.Bennani YL.Crispino GA.Hartung J.Jeong KS.Kwong HL.Morikawa K.Wang ZM.Xu D.Zhang XL. J. Org. Chem. 1992, 57: 2768 - 10
Frohn M.Dalkiewicz M.Tu Y.Wang ZX.Shi Y.
J. Org. Chem. 1998, 63: 2948 -
11a
Padron JM.Kokotos G.Mart T.Markidis T.Gibbons WA.Mart VS. Tetrahedron: Asymmetry 1998, 9: 3381 -
11b
Adamczyk M.Johnson DD.Reddy RE. Tetrahedron: Asymmetry 1999, 10: 775 - 12
Desai D.Sharma AK.Lin J.-M.Krzeminski J.Pimentel M.El-Bayoumy K.Nesnow S.Amin S. Chem. Res. Toxicol. 2002, 15: 64 - 13
Sharma AK.Gowdahalli K.Gimbor M.Amin S. Chem. Res. Toxicol. 2008, 21: 154 - 14
O’Sullivan TP.Zhang H.Mander LN. Org. Biomol. Chem. 2007, 5: 2627 - 15
Liu G.Romo D. Org. Lett. 2008, 11: 1143 - 16
Srikrishna A.Babu RR. Tetrahedron 2008, 64: 10501 - 17
Brouillette Y.Martinez J.Lisowski V. J. Org. Chem. 2009, 74: 4975